Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Diseases, Interstitial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Large-scale testing (Phase 3)Study completedNCT00430105
What this trial is testing

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

Who this might be right for
ANCA Associated Systemic VasculitisWegener's GranulomatosisMicroscopic Polyangiitis
Cambridge University Hospitals NHS Foundation Trust 160
Not applicableStudy completedNCT03516994
What this trial is testing

Reducing Disparities in the Quality of Advance Care Planning for Older Adults

Who this might be right for
Metastatic CancerCongestive Heart FailureChronic Obstructive Pulmonary Disease+6 more
Duke University 790
Early research (Phase 1)Study completedNCT01725139
What this trial is testing

A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05925803
What this trial is testing

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Who this might be right for
Systemic SclerosisScleroderma
AstraZeneca 314
Not applicableUnknownNCT04807127
What this trial is testing

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

Who this might be right for
Pneumonitis, InterstitialImmunotherapyImmune-related Adverse Events
Universitaire Ziekenhuizen KU Leuven 60
Testing effectiveness (Phase 2)Study completedNCT01529853
What this trial is testing

To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sanofi 24
Not applicableUnknownNCT04019080
What this trial is testing

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Who this might be right for
Idiopathic Pulmonary Fibrosis
Karolinska University Hospital 400
Testing effectiveness (Phase 2)UnknownNCT04632342
What this trial is testing

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Who this might be right for
Radiation PneumonitisLung Cancer
Hanlim Pharm. Co., Ltd. 87
Not applicableLooking for participantsNCT07320846
What this trial is testing

The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis

Who this might be right for
ExercisePulmonary RehabilitationInterstitial Lung Disease+3 more
Saglik Bilimleri Universitesi 39
Testing effectiveness (Phase 2)Ended earlyNCT05032066
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Amgen 153
Early research (Phase 1)WithdrawnNCT04333251
What this trial is testing

Study Testing Convalescent Plasma vs Best Supportive Care

Who this might be right for
Pneumonia, Interstitial
Baylor Research Institute
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Large-scale testing (Phase 3)Looking for participantsNCT07176546
What this trial is testing

TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

Who this might be right for
Granulomatosis With PolyangiitisWegener'sGPA
Robert Spiera, MD 30
Testing effectiveness (Phase 2)Study completedNCT00048373
What this trial is testing

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

Who this might be right for
Histiocytosis, Langerhans-Cell
Baylor College of Medicine 20
Not applicableLooking for participantsNCT07743996
What this trial is testing

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 100
Not applicableStudy completedNCT00001759
What this trial is testing

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

Who this might be right for
AsthmaHypersensitivityLung Diseases+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 95
Not applicableStudy completedNCT05631756
What this trial is testing

Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit

Who this might be right for
Interstitial Lung Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 86
Large-scale testing (Phase 3)UnknownNCT05596786
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Disease (ILD) With Inflammatory Component: a Multicentre Double-blind Placebo-controlled Randomized Trial

Who this might be right for
Lung Diseases
University Hospital, Tours 126
Post-approval studies (Phase 4)Study completedNCT03503188
What this trial is testing

Digital Auscultation Test - IPF Data Collection

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 274
Next Page